NICCOLAI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.642
EU - Europa 5.357
AS - Asia 4.255
SA - Sud America 501
AF - Africa 109
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.531
RU - Federazione Russa 1.525
IT - Italia 1.227
PL - Polonia 1.183
CN - Cina 1.181
SG - Singapore 1.167
HK - Hong Kong 583
BR - Brasile 404
KR - Corea 366
VN - Vietnam 346
IE - Irlanda 307
SE - Svezia 220
FR - Francia 207
FI - Finlandia 204
DE - Germania 151
IN - India 145
GB - Regno Unito 110
BD - Bangladesh 100
ID - Indonesia 77
NL - Olanda 68
CA - Canada 65
AU - Australia 59
JO - Giordania 59
JP - Giappone 48
ES - Italia 45
TR - Turchia 34
MX - Messico 29
AR - Argentina 27
IQ - Iraq 22
ZA - Sudafrica 22
EC - Ecuador 18
UA - Ucraina 17
CI - Costa d'Avorio 16
CO - Colombia 16
PK - Pakistan 16
CH - Svizzera 15
NG - Nigeria 15
AT - Austria 14
LT - Lituania 13
BE - Belgio 12
PH - Filippine 12
VE - Venezuela 12
SA - Arabia Saudita 11
TW - Taiwan 11
EG - Egitto 10
IR - Iran 10
CL - Cile 9
UZ - Uzbekistan 9
MA - Marocco 8
PY - Paraguay 8
TN - Tunisia 8
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
LB - Libano 7
NP - Nepal 7
BJ - Benin 6
DK - Danimarca 6
DZ - Algeria 6
KG - Kirghizistan 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
MY - Malesia 5
UG - Uganda 5
DO - Repubblica Dominicana 4
PE - Perù 4
PT - Portogallo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
GH - Ghana 3
JM - Giamaica 3
OM - Oman 3
AM - Armenia 2
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
ML - Mali 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BO - Bolivia 1
BW - Botswana 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
Totale 16.913
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.183
Warsaw 1.182
Ashburn 983
Singapore 874
Hong Kong 528
Fairfield 449
Hefei 364
Seoul 362
Dublin 303
San Jose 286
Chandler 265
Florence 211
Seattle 211
Beijing 194
Woodbridge 192
Houston 186
Cambridge 173
Council Bluffs 166
Milan 159
Los Angeles 138
Wilmington 129
Ho Chi Minh City 115
Helsinki 113
Lawrence 108
Altamura 106
Lauterbourg 104
Rome 96
The Dalles 95
Ann Arbor 93
Buffalo 91
Munich 90
Princeton 82
Dallas 81
New York 81
Hanoi 70
Chicago 64
Jakarta 58
Mumbai 55
Boston 52
Melbourne 52
Kent 51
Moscow 49
San Diego 45
Paris 43
Tokyo 42
Bologna 33
Shanghai 32
São Paulo 32
Lappeenranta 31
Dong Ket 30
Boardman 29
Medford 29
Clifton 28
Orem 28
Salt Lake City 24
Bengaluru 23
Frankfurt am Main 23
London 23
Turku 23
Guangzhou 22
Turin 21
Redondo Beach 19
Toronto 18
Genoa 17
Phoenix 17
Abidjan 16
West Jordan 16
Da Nang 15
Hillsboro 15
Abuja 14
Brooklyn 14
Fiesole 14
Haiphong 14
Johannesburg 14
Atlanta 13
Bern 13
Montreal 13
Bari 12
Denver 12
Elk Grove Village 12
Pune 12
Yubileyny 12
Amsterdam 11
Chennai 11
Figino 11
Manchester 11
Naples 11
Rio de Janeiro 11
Vienna 11
Baghdad 10
Brussels 9
Cairo 9
Pescara 9
San Francisco 9
Stockholm 9
Tampa 9
Barcelona 8
Bogotá 8
Curitiba 8
Falls Church 8
Totale 11.280
Salva come PNG Salva come JPEG
Nome #
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 397
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 352
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 285
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 273
Evaluation and comparison of short chain fatty acids composition in gut diseases 265
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 261
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 256
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 256
Studio della risposta T immuno-specifica in corso di tumori dell'apparato digerente 252
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 249
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 242
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 236
Nourishing Immunity and Combatting Neuroinflammation: The Power of Immunonutrition and The Microbiome 234
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 234
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 228
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 227
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 224
Gastric cancer and the epoch of immunotherapy approaches 223
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 219
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 214
Thrombosis in vasculitis: from pathogenesis to treatment 211
Broad targeting of angiogenesis for cancer prevention and therapy 209
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 203
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 199
Designing a broad-spectrum integrative approach for cancer prevention and treatment 198
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 196
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 196
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 195
Broad targeting of resistance to apoptosis in cancer 191
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 191
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 188
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 185
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 183
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 182
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 182
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 181
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 179
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 178
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 176
A multi-targeted approach to suppress tumor-promoting inflammation 175
Cancer prevention and therapy through the modulation of the tumor microenvironment 173
Circulating miRNome profiling data in Behçet's syndrome 173
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 172
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 171
Differential Diagnosis 169
Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study 169
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease 168
Adverse Effects of Micro- and Nanoplastics on Humans and the Environment 167
Exploring Plasma-Level Gut Microbiota Mediators and Pro-Inflammatory Markers in Pregnant Women with Short Cervix and Gestational Diabetes Mellitus 165
Alterations of circulating free fatty acids in patients with pemphigus vulgaris 162
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 161
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane 160
Machine learning for analysis of gene expression data in fast- and slow-progressing amyotrophic lateral sclerosis murine models 158
The first taxonomic and functional characterization of human CAVD-associated microbiota 155
Microparticles: Bridging the gap between autoimmunity and thrombosis 155
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice 153
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds 152
Novel immunotherapeutic strategies of gastric cancer treatment 150
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition 150
MICROBIOTA-INFLAMMATION-BRAIN AXIS IN HEART FAILURE: NEW FOOD, BIOMARKERS AND AI APPROACH FOR THE PREVENTION OF UNDERNUTRITION IN OLDER-AMBROSIA 148
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes 146
The Future Exploring of Gut Microbiome-Immunity Interactions: From In Vivo/Vitro Models to In Silico Innovations 145
HELICOBACTER PYLORI HP0175 PROMOTES THE PRODUCTION OF IL-23, IL-6, IL-1 beta AND TGF-beta 144
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. 144
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 144
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 144
Utilization of formalin-fixed paraffin-embedded specimens for microbiota characterization in cancer: utility and concern 143
What is recent in pancreatic cancer immunotherapy? 143
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 143
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 142
Gastritis in Helicobacter pylori infection 141
Experimental tests challenge the evidence of a healthy human blood microbiome 138
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 138
T cells, tissue factor and malignancy 138
Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy 137
Rummeliibacillus suwonensis: First Time Isolation from Human Feces by Culturomics 135
GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin 133
Synergistic Strategies for Gastrointestinal Cancer Care: Unveiling the Benefits of Immunonutrition and Microbiota Modulation 131
Gut-lung microbiota dynamics in mice exposed to Nanoplastics 130
Cytokine and microbiota profiles in obesity-related hypertension patients 125
Therapeutic targeting of replicative immortality 124
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 123
Role of immune response in yersinia pestis infection. 122
Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies 122
Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease 121
Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment 115
Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers 113
TDP-43-immunity-microbiota axis in amyotrophic lateral sclerosis: A potential pathogenic mechanism 105
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 104
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy 100
Rheumatic diseases: The microbiota-immunity axis in development and treatment 96
Six-Month Synbio® Administration Affects Nutritional and Inflammatory Parameters of Older Adults Included in the PROBIOSENIOR Project 94
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 91
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 90
Plant and Marine Sources: Biological Activity of Natural products and therapeutic Use 88
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 88
Dysregulated metabolism contributes to oncogenesis 83
Potential Association of the Oral Microbiome with Trimethylamine N-Oxide Quantification in Mexican Patients with Myocardial Infarction 81
Editorial: Microbiota in tumors: is it a new hope for treatment? 44
Compositional and Functional Disparities in the Breast Oncobiome Between Patients Living in Urban or Rural Areas 41
Totale 16.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/2022483 14 22 75 25 4 22 14 66 17 18 62 144
2022/20231.335 120 317 70 73 74 202 183 71 134 21 31 39
2023/2024690 19 56 107 36 42 112 33 124 11 69 29 52
2024/20254.767 132 442 291 692 1.127 534 166 305 210 194 320 354
2025/20266.915 771 895 753 604 687 282 758 323 511 428 258 645
Totale 17.198